Syntropic Medical

Syntropic Medical develops Haven, a non-invasive medical headset that uses 60 Hz visual neuromodulation to treat Major Depressive Disorder. The device delivers precise light stimulation to trigger the brain's immune cells, aiming to restore neuroplasticity by opening perineuronal nets. The therapy is designed for patients with depression as a drug-free alternative to traditional antidepressants, with a target for regulatory clearance by 2028.